How might Rightway optimize its pharmacy benefits management service to help employers further reduce prescription drug costs?

Introduction

To optimize Rightway's pharmacy benefits management service and help employers further reduce prescription drug costs, we need to take a comprehensive approach that addresses the complex ecosystem of healthcare, pharmaceuticals, and employer-sponsored benefits. I'll outline a strategic plan to tackle this challenge, focusing on key stakeholders, pain points, and innovative solutions.

Step 1

Clarifying Questions (5 mins)

• Looking at the product context, I'm thinking Rightway might be operating in a highly competitive market with increasing pressure from both traditional PBMs and new digital health entrants. Could you provide some insight into Rightway's current market position and primary differentiators?

Why it matters: Determines if we focus on enhancing existing strengths or developing new capabilities Expected answer: Rightway is a mid-sized player with a strong digital-first approach and personalized member experience Impact on approach: Would emphasize leveraging technology and data analytics to further personalize and optimize drug spend

• Considering the focus on reducing costs, I'm curious about the current utilization patterns and cost drivers. Can you share any data on the top therapeutic categories driving spend for Rightway's employer clients?

Why it matters: Helps identify specific areas where cost reduction efforts should be concentrated Expected answer: Specialty drugs, particularly in oncology and autoimmune diseases, are the fastest-growing cost drivers Impact on approach: Would prioritize solutions targeting high-cost specialty medications and chronic condition management

• Given the complexity of the healthcare ecosystem, I'm wondering about Rightway's current partnerships and integrations. Could you elaborate on any existing collaborations with drug manufacturers, healthcare providers, or digital health companies?

Why it matters: Identifies potential leverage points and opportunities for expanding the value proposition Expected answer: Some partnerships with digital health companies for chronic condition management, limited direct relationships with manufacturers Impact on approach: Would explore expanding strategic partnerships and developing a more comprehensive care ecosystem